Adam Fox is a Professor of Paediatric Allergy and consultant in the UK’s largest specialist allergy service at Guy’s & St Thomas’ Hospitals, where he is also the Deputy Medical Director. As well as his extensive clinical experience in all aspects of allergy affecting children, Prof. Fox's involvement in academic medicine allows him to offer the latest in specialist treatments.
He is the founding Director of the King’s College London Allergy Academy, a trustee of Allergy UK and chair of their Health Advisory Board. He is also President of the British Society of Allergy & Clinical Immunology, the first Paediatrician to have been elected to this role.
Watch Professor Fox being featured on ITV's 'This Morning' here.
Prof. Adam Fox began his academic journey by studying Medicine and Neuroscience at Cambridge University, followed by clinical training at University College London. Specialising in Paediatric Allergy in 2006, he became one of the founding consultants of the Allergy Service at St Thomas’ Hospitals, London, now recognised as one of Europe’s largest and most distinguished specialist Allergy services. For nine years, he served as the clinical lead for both adult and paediatric allergy at Guy’s & St Thomas’ Hospitals. Under his leadership, the service earned the distinction of being an International Centre of Excellence by the World Allergy Organisation and GALEN.
In addition to his clinical achievements, he is a Professor of Paediatric Allergy at King’s College London and the founding Director of the KCL Allergy Academy, a postgraduate educational initiative that was a finalist at the BMJ Awards in 2018.
Prof. Fox chaired the UK Department of Health's National Care Pathway for Food Allergy in Childhood and contributed as a member of the NICE guideline development group for food allergy assessment in children. He served as senior author of the iMAP guideline, which received the Allergy UK Innovation Award in 2018. As the first paediatrician elected President of the British Society of Allergy & Clinical Immunology (BSACI), Prof. Fox held this role from 2018 to 2021 and has since chaired the National Allergy Strategy Group. He jointly leads the Expert Advisory Group for Allergy with the Department of Health and Social Care. In 2024, his extraordinary contributions were recognised with the BSACI Fellows Award, making him only the second individual to receive this accolade.
Dr. Fox’s accolades include the 2007 ‘Paediatric Allergist of the Year’ award from Allergy UK, the prestigious Raymond Horton Smith prize from Cambridge University for his doctoral research on peanut allergy, and the William Frankland Award from BSACI in 2015. He has received multiple National Clinical Excellence Awards from the UK Department of Health and was included in The Times’ list of ‘Britain’s 100 Best Children’s Doctors’ in 2012.
With a passion for education and innovation, Dr. Fox has delivered lectures worldwide, published over 100 research articles in leading medical journals, and contributed to numerous documentaries. He is also a familiar face on ITV’s This Morning and BBC’s Morning Live.
His private practice, Allergy London, has been widely acclaimed, earning the title of ‘Best Allergy Clinic – London’ in the 2019 Global Health & Pharma Private Healthcare Awards and being recognised as Best Allergy Testing Specialists in the 2020 Private Healthcare Awards. He also co-established The Food Allergy Immunotherapy Centre at Great Ormond St Hospital in 2021, where he oversaw the world’s first administration of Palforzia, the first licensed food allergy desensitisation product outside the US.
Professor Fox ensures that all problem foods are correctly identified using allergy tests such as skin prick testing, specific IgE blood testing, atopy patch testing or provocation challenges. Common allergic problems such as eczema and asthma, which often accompany food allergy, are also identified and treated. When an allergen is identified and excluded from the diet, Prof. Fox is able to offer advice on substitutes for essential nutrients and on how to recognise and deal with any subsequent reactions that may occur accidentally, as well as offer desensitisation (food OIT) for select allergens such as milk, egg and peanut.
Eczema affects 15-20% of school children, in some cases with a significant impact on quality of life. Prof. Fox combines a detailed clinical history with allergy testing to identify and exclude food or environmental allergens, helping to improve eczema and lessen the need for steroids.
Over 1 million children in the UK suffer with asthma. The identification of allergens, used in conjunction with other treatments, can lead to effective control of symptoms. Prof. Fox uses the latest monitoring techniques such as computerised spirometry and exhaled nitric oxide measurement. He is at the forefront of the development of sublingual immunotherapy (a desensitisation process where drops are placed under the tongue daily to lessen an allergic reaction) and anti-IgE therapy for children whose symptoms do not respond to conventional therapies.
Hay fever (allergic rhinitis) is a distressing and irritating condition, affecting approximately 15% of children. It can adversely affect quality of sleep and impact on school life. Following correct identification of the causative allergen, hay fever can be treated with safe medication. There are children for whom this approach is less effective, and in these cases Prof. Fox is now able to offer the new specialist treatment of sublingual immunotherapy. This is available for grass and tree pollen, dust mite, cat, dog and horse allergies.
As one of the UK's few accredited specialist paediatric allergists, Prof. Fox does not look to treat a condition in isolation but looks beyond the presenting problems to consider their underlying cause. He aims to treat the child as a whole, considering how the symptoms and the treatment of one condition will impact those of the others. Prof. Fox work in the UK's largest NHS children's allergy service, Guy's and St Thomas and ongoing involvement in academic medicine allows him to bring the most up to date specialist treatments to his patients before they are available outside of the specialist arena.
Principle Investigator for Guy's & St Thomas' Hospital for 2 international multicentre trials: - GAP study - using desensitisation to prevent the development of asthma in high risk allergic children - PAICE study investigating role of pre/probiotics in accelerating tolerance in milk allergic children.
Prof. Adam Fox's skill and experience has led to him speaking about his field on a number of different platforms. These include on national television, research papers and peer reviewed journals. You can find out more about Prof. Fox's work with the media at www.allergylondon.com/press.
